A 72-year-old woman who was a hemodialysis patient presented with an impaired mental status several days after undergoing coronary angioplasty for angina pectoris. Livedo reticularis was noted on both feet ([Picture 1](#g001){ref-type="fig"}). Magnetic resonance imaging showed acute multiple brain infarctions in the bilateral cerebral hemispheres and cerebellum ([Picture 2](#g002){ref-type="fig"}). The cutaneous and funduscopic features combined with the imaging findings led to a diagnosis of cholesterol embolization syndrome with neurological involvement ([Picture 3](#g003){ref-type="fig"}). The patient\'s urine output on admission was \<100 mL/day. A complete recovery from her neurological symptoms and an increased urine volume were observed after 4 weeks of corticosteroid therapy.
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The clinical manifestations of cholesterol embolization syndrome consist of signs and symptoms related to end-organ damage and systemic inflammation. The involvement of the central nervous system is reflected by an altered mental status, transient ischemic attack, or focal neurological deficits ([@B1]). A definitive diagnosis can only be made when cholesterol crystals are demonstrated in the occluded arterioles; thus, protruding aortic atheroma (as illustrated in [Picture 4](#g004){ref-type="fig"}) and other clinical signs should also be considered when diagnosing neurological embolization ([@B1]). Since it is possible that anticoagulation therapy may worsen atheromatous embolization ([@B2]), accurately differentiating the pathology from cardiogenic embolism is of critical importance.
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